0
Orchard Therapeutics plc Banner Image

Orchard Therapeutics plc has reached its limit for free report views

Work for Orchard Therapeutics plc? Upgrade Your Profile and unlock all your annual reports.

Orchard Therapeutics plc

  • Ticker ORTX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Orchard Therapeutics plc Logo Image
  • 201-500 Employees
  • Based in London, England
Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by rare diseases through the development of innovative, potentially curative gene therapies. Our ex vivo autologous gene therapy approach harnesses the power of genetically modified blood stem cells and seeks to correct the underlying cause of disease in a single administration. InMore 2018, Orchard acquired GSK’s rare disease gene therapy portfolio, which originated from a pioneering collaboration between GSK and the San Raffaele Telethon Institute for Gene Therapy in Milan, Italy. Orchard now has one of the deepest and most advanced gene therapy product candidate pipelines in the industry spanning multiple therapeutic areas where the disease burden on children, families and caregivers is immense and current treatment options are limited or do not exist.
Orchard Therapeutics plc

Most Recent Annual Report

Orchard Therapeutics plc MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Orchard Therapeutics plc has reached its limit for free report views.

Older/Archived Annual Reports